CHICAGO EQUITY PARTNERS LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$1,211,000
+72.8%
57,225
+32.0%
0.07%
+228.6%
Q4 2017$701,000
-84.5%
43,350
-86.6%
0.02%
-85.3%
Q3 2017$4,520,000
+111.3%
323,320
+33.5%
0.14%
+146.6%
Q2 2017$2,139,000
-9.1%
242,260
-33.4%
0.06%
-14.7%
Q1 2017$2,353,000
+171.7%
363,755
+54.1%
0.07%
+195.7%
Q4 2016$866,000
+29.8%
236,055
+15.0%
0.02%
+27.8%
Q3 2016$667,000
+158.5%
205,345
+84.9%
0.02%
+125.0%
Q2 2016$258,000111,0600.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders